Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Addressing Antimicrobial Resistance and Stewardship

Addressing Antimicrobial Resistance and Stewardship This Viewpoint describes the Priority Antimicrobial Value and Entry (PAVE) award, which has been proposed to address the problem of antimicrobial-resistant infections using limited public funds to shift to value-based payment for new, high-priority antimicrobial drugs. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Addressing Antimicrobial Resistance and Stewardship

JAMA , Volume 318 (12) – Sep 26, 2017

Loading next page...
 
/lp/american-medical-association/addressing-antimicrobial-resistance-and-stewardship-KKkAk8AbjV
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2017.10164
pmid
28772301
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint describes the Priority Antimicrobial Value and Entry (PAVE) award, which has been proposed to address the problem of antimicrobial-resistant infections using limited public funds to shift to value-based payment for new, high-priority antimicrobial drugs.

Journal

JAMAAmerican Medical Association

Published: Sep 26, 2017

References